Potentially inappropriate medication use is associated with increased risk of incident disability in healthy older adults

被引:7
|
作者
Lockery, Jessica A. [1 ,2 ]
Collyer, Taya L. [3 ]
Woods, Robyn G. [2 ]
Orchard, Suzanne [2 ]
Murray, Anne R. [4 ,5 ]
Nelson, Mark P. [2 ,6 ]
Stocks, Nigel [7 ]
Wolfe, Rory [2 ]
Moran, Chris E. [2 ]
Ernst, Michael [8 ,9 ]
机构
[1] RMIT Univ, Sch Hlth & Biomed Sci, Canc Ageing & Vaccines Res Grp, Bundoora, Vic, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[3] Monash Univ, Peninsula Clin Sch, Melbourne, Vic, Australia
[4] Hennepin Healthcare, Hennepin Healthcare Res Inst, Minneapolis, MN USA
[5] Univ Minnesota, Dept Med, Div Geriatr, Minneapolis, MN USA
[6] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia
[7] Univ Adelaide, Discipline Gen Practice, Adelaide, SA, Australia
[8] Univ Iowa, Coll Pharm, Dept Pharm Practice & Sci, Iowa City, IA USA
[9] Univ Iowa, Carver Coll Med, Dept Family Med, Iowa City, IA USA
基金
英国医学研究理事会;
关键词
2019 AGS Beers Criteria; disablement process; drug related; hospital related; REDUCING EVENTS; ANTICHOLINERGIC BURDEN; MORTALITY; OUTCOMES; ASPIRIN; METAANALYSIS; ADMISSIONS; CRITERIA; PEOPLE; COHORT;
D O I
10.1111/jgs.18353
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Efforts to minimize medication risks among older adults include avoidance of potentially inappropriate medications (PIMs). However, most PIMs research has focused on older people in aged or inpatient care, creating an evidence gap for community-dwelling older adults. To address this gap, we investigated the impact of PIMs use in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial cohort.Methods: Analysis included 19,114 community-dwelling ASPREE participants aged 70+ years (65+ if US minorities) without major cardiovascular disease, cognitive impairment, or significant physical disability. PIMs were defined according to a modified 2019 AGS Beers Criteria. Cox proportional-hazards regression models were used to estimate the association between baseline PIMs exposure and disability-free survival, death, incident dementia, disability, and hospitalization, with adjustment for sex, age, country, years of education, frailty, average gait speed, and comorbidities.Results: At baseline, 7396 (39% of the total) participants were prescribed at least one PIM. Compared with those unexposed, participants on a PIM at baseline were at an increased risk of persistent physical disability (adjusted hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.21, 1.80) and hospitalization (adjusted HR 1.26, 95% CI 1.20, 1.32), but had similar rates of disability-free survival (adjusted HR 1.02; 95% CI 0.93, 1.13) and death (adjusted HR 0.92, 95% CI 0.81, 1.05). These effects did not vary by polypharmacy status in interaction analyses. PIMs exposure was associated with higher risk of disability followed by hospitalization (adjusted HR 1.92, 95% CI 1.25, 2.96) as well as vice versa (adjusted HR 1.54, 95% CI 1.15, 2.05). PPIs, anti-psychotics and benzodiazepines, were associated with increased risk of disability.Conclusions: PIMs exposure is associated with subsequent increased risk of both incident disability and hospitalization. Increased risk of disability prior to hospitalization suggests that PIMs use may start the disability cascade in healthy older adults. Our findings emphasize the importance of caution when prescribing PIMs to older adults in otherwise good health.
引用
收藏
页码:2495 / 2505
页数:11
相关论文
共 50 条
  • [1] POTENTIALLY INAPPROPRIATE MEDICATION USE INCREASES RISK OF INCIDENT DISABILITY IN HEALTHY OLDER ADULTS
    Lockery, Jessica
    Collyer, Taya
    Woods, Robyn
    Orchard, Suzanne
    Murray, Anne
    Ernst, Michael
    [J]. INNOVATION IN AGING, 2022, 6 : 751 - 751
  • [2] Incident Use and Outcomes Associated With Potentially Inappropriate Medication Use in Older Adults
    Dedhiya, Seema D.
    Hancock, Emily
    Craig, Bruce A.
    Doebbeling, Caroline C.
    Thomas, Joseph, III
    [J]. AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (06): : 562 - 570
  • [3] Risk of Mortality Associated with Potentially Inappropriate Medication Use Including Opioids in Older Adults
    D'Aiuto, Carina
    Lunghi, Carlotta
    Guenette, Line
    Berbiche, Djamal
    Bertrand, Karine
    Vasiliadis, Helen-Maria
    [J]. DRUG SAFETY, 2024, 47 (08) : 799 - 807
  • [4] Health outcomes associated with potentially inappropriate medication use in older adults
    Fick, Donna M.
    Mion, Lorraine C.
    Beers, Mark H.
    Waller, Jennifer L.
    [J]. RESEARCH IN NURSING & HEALTH, 2008, 31 (01) : 42 - 51
  • [5] Potentially inappropriate medication use and incident dementia in privately-insured older adults
    Martinez, Ashley I.
    Jicha, Gregory A.
    Moga, Daniela C.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 294 - 295
  • [6] Risk factors for potentially inappropriate medication use in older adults: a cohort study
    Natacha Christina de Araújo
    Erika Aparecida Silveira
    Brenda Godoi Mota
    Rafael Alves Guimarães
    Ana Carolina Figueiredo Modesto
    Valéria Pagotto
    [J]. International Journal of Clinical Pharmacy, 2022, 44 : 1132 - 1139
  • [7] Risk factors for potentially inappropriate medication use in older adults: a cohort study
    de Araujo, Natacha Christina
    Silveira, Erika Aparecida
    Mota, Brenda Godoi
    Guimaraes, Rafael Alves
    Figueiredo Modesto, Ana Carolina
    Pagotto, Valeria
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (05) : 1132 - 1139
  • [8] Clinical and health outcomes associated with potentially inappropriate medication use in older adults
    Fick, D
    Mion, L
    Spokus, D
    [J]. GERONTOLOGIST, 2005, 45 : 440 - 441
  • [9] Potentially inappropriate anticholinergic medication use in older adults with dementia
    Kachru, Nandita
    Carnahan, Ryan M.
    Johnson, Michael L.
    Aparasu, Rajender R.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2015, 55 (06) : 603 - 612
  • [10] Potentially Inappropriate Medication Use in Older Adults With Multimorbidity in Taiwan
    Chang, Betty Chia-Chen
    Lai, I-Hua
    Ng, Yee-Yung
    Wu, Shiao-Chi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (09)